^{International Conference on} Cancer Treatment and Prevention December 14-15, 2020 Tokyo, Japan

Dr. Nelson graduated from Queens University Belfast Medical School in 1992 and commences as Junior House Officer at the Royal Victoria Hospital. Initially, Dr. Nelson undertook surgical training in the Belfast Surgical Training Scheme then entered the Hull and East Yorkshire Radiology Training Scheme in 1996, becoming a Fellow of the Royal College of Radiologists in 2001 with subspecialty training in Radio nucleotide Radiology. Dr Nelson was appointed to the Northern Health and Social Care Trust in 2001 and is presently Bowel Cancer Screening Programme for Northern Ireland Radiology QA lead, Honorary Lecturer at Queens University Belfast, Deputy Radiology Specialty Adviser to Chief Medical Officer for Northern Ireland and Clinical Radiology Lead for 3Fivetwo Group. Previously Dr Nelson was Clinical Director for Medical Diagnostic Specialties (2004-2010), Deputy Medical Director for Acute services (2013-2014) and Associate medical director for Unscheduled Care (2014-2015). Dr Nelson is on various medical committees and groups including Modernising Radiology Clinical Network, Colorectal Clinical Reference Group, and Multidiscipline Team Effectiveness Steering Group. Dr. Nelson has published and presented 14 Radiology articles.

Clinical Radiology

Dr. Yumin Zhang, is an Associate Professor in the Department of Anatomy, Physiology and Genetics and the Department of Neuroscience at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Zhang obtained his MD in Binzhou Medical School, China, PhD in Hebrew University of Jerusalem, Israel, and postdoc study in the Children’s Hospital, Harvard Medical School. The major research interest in Dr. Zhang’s lab is to study how modulation of the arachidonic acid metabolism and the endocannabinoid system can impact the pathogenesis and treatment for neurological diseases, including traumatic brain injury and multiple sclerosis.

neurological diseases, including traumatic brain injury and multiple sclerosis

Prissadee Thanaphongdecha has done Doctoral of philosophy in Pathobiology and Bachelor degree in Medical science. He is currently working in Faculty of medicine, Khonkaen university, Thailand

Pathobiology

Dr Catherine Maurice completed her residency training in Neurology at the University of Montreal in 2013. She then started a 2-year fellowship in neuro-oncology at the Pencer Brain Tumor Centre of Princess Margaret Hospital, Toronto, under the supervision of Dr Warren P. Mason. In 2015, University of Toronto Health Network recruited Dr. Catherine Maurice to work as an attending physician and clinical teacher. She developed a new neuro-oncology clinic focusing on the to assessment of neurologic complications resulting from systemic cancers and novel therapies. She also manages another clinic focused on primary brain tumors and is enrolled in the multidisciplinary Gamma-Knife Clinic of the Krembil Neuroscience Centre. Dr. Maurice is actively involved in teaching, trying to incorporate new technologies and virtual reality into medical education.

Neurooncology, Brain Tumor and Glioblastoma..

Dr. Paulus S. Wang was a professor of the Department of Physiology, National Yang-Ming University (NYMU). Now he is a Chair-Professor and also the Director in the Medical Center of Aging Research, China Medical University Hospital (CMUH). During his academic life in NYMU and CMUH. Dr. Wang creates the concept that the lactate caused by exercise stimulates the productions of progesterone in females and testosterone in males and that both digitalis and bufalin inhibit the proliferation of different human prostate cancer cells. He established the Master and Ph. D. programs for the Institute of Physiology in NYMU. He is the Founder of both the Society of Adaptive Science in Taiwan (SAST) and the Taiwan Society of Endocrinology and Metabolism (TSEM).

Oncology ,Physiology